cytomegalovirus, influencing the assembly of gH/gL complexes and virion 7 infectivity. ABSTRACT 
expression of UL128-131 was suppressed in ME, virions contained dramatically less cells. Instead, ME-infected cells contained two species that were less abundant, and of faster 146 and slower electrophoretic motilities than the single UL148 species detected in TR-infected 147 cells. The basis of the apparent size difference was not characterized, but could reflect 148 differences in translational start/stop codon usage, splicing of the UL148 mRNA, or 149 posttranslational modifications of the UL148 protein between strains. Overall, the pattern of 150 expression of the UL128-131, and UL148 proteins correlated well with the previously described 151 pentamer-rich nature of ME virions and the trimer-rich nature of TR virions (25, 30) . Note that 152 the expression of gO was not addressed in these analyses because the gO amino acid 153 sequence differences between strains affects antibody recognition and precluded direct 154 comparison (30). 155
Trafficking of gH/gL from the ER to TGN-derived assembly compartments was assessed 156 by treating the 5 dpi infected-cell extracts with either endoglycosidase H (endo H) or PNGaseF, levels because antibodies do not cross-react (30) . Furthermore, these sequence differences 171 could potentially affect the ability of the distinct gO isoforms to compete with the UL128-131 172 proteins for binding to gH/gL (thus influencing the amounts of gH/gL complexes in the mature 173 virion envelope), or the function(s) of gO during entry, such as binding PDGFR or other 174 receptors. To address these possibilities, BAC recombineering methods were used to replace 175 the gO ORF (UL74) of TR with the analogous sequences from ME, and visa versa to generate 176 recombinant viruses denoted TRMEgO and METRgO. 177 Zhou 2015 demonstrated a positive correlation between the infectivity of HCMV virions 178 and the amounts of gH/gL/gO in the virion envelope (25). To assess the effects of gO 179 sequences on infectivity, cell free virus stocks of parental wild type and heterologous gO 180 recombinants were analyzed by qPCR to determine the number of virions, and infectivity was 181 determined by plaque assay. No difference in particles/PFU was observed between TR and the 182 corresponding recombinant, TR_MEgO ( Fig 3A) , or between ME and the corresponding 183 recombinant ME_TRgO (Fig 3B) . When the ME-based HCMV were grown in HFFFtet cells, 184 which repress UL128-131 expression, the resultant virions, ME-T and ME-TTRgO, were 185 dramatically more infectious, as shown before (25) (33), but consistently there were no 186 differences due to the isoform of gO expressed (Fig. 3B ). In parallel analyses, the amounts of 187 gH/gL complexes were analyzed by non-reducing immunoblot probing for gL to detect intact, 188 disulfide linked gH/gL/gO, and disulfide-linked gH/gL/UL128 (note that UL130 and UL131 are 189 not disulfide-linked to the intact pentamer complex and are thus separated by SDS-PAGE) ( Fig   190   4 ). Consistent with our previous reports (25, 30) , TR virions contained much greater amounts 191 of total gH/gL, mostly in the form of gH/gL/gO, whereas ME virions contained less gH/gL, mostly 192 as gH/gL/UL128-131. Repression of the UL128-131 proteins (ME-T) drastically reduced the 193 amount of gH/gL/UL128-131, and increased the amount of gH/gL/gO. However, note that the indicating that the repression of UL128-131 was not fully compensated by gO. In no case did 196 expression of the heterologous gO isoform detectably influence the amounts of gH/gL 197 complexes in HCMV virions. Together these results suggest that the amino acid sequence 198 differences between TR and ME gO do not influence gH/gL complex assembly, or the function 199 of gO in entry into fibroblasts.
200

ME expresses less gO during replication than TR.
The heterologous gO 201 recombinants allowed comparison of gO expression level between TR and ME. In the first 202 analyses cells infected with parental or the heterologous gO recombinants were analyzed by 203 reducing immunoblot using TR and ME specific anti-gO antibodies (30) ( Fig 5) . TR-specific gO 204 antibodies detected two bands in TR-infected cells, a prominent species migrating just above 205 the 100kDa marker, and a minor, more diffuse species migrating at approximately 130-140kDa.
206
The ME-specific antibodies detected similarly migrating bands in TR_MEgO infected cells, 207 however their relative abundance appeared more equal. No similar bands were detected in 208 cells infected with ME or ME_TRgO analyzed with either gO antiserum. The failure to detect 209 either isoform of gO in cells infected with ME-based HCMV suggested that protein expression 210 from the UL74 locus of ME was lower than in TR.
211
To directly compare differences in glycoprotein expression between TR and ME, infected 212 cells were labeled with [35]S-methionine/cysteine for 15 min, then analyzed by 213 immunoprecipitation with anti-peptide antibodies specific for gH, gL, or gO, followed by SDS-214 PAGE and band density analysis (Fig 6, Tables 1 and 2). Two approaches were taken to allow 215 for direct quantitative comparisons of labeled-proteins between extracts. First, cell extracts 216 were denatured and reduced with SDS/DDT prior to immunoprecipitation to allow maximum 217 epitope access by the anti-peptide antibodies.
Second, for each analysis, multiple 218 immunoprecipitation reactions were performed in parallel with increasing amounts of protein 219 extract input to insure that antibodies were not limiting. In these experiments, expression of gH than for ME, but gO expression was strikingly 27-fold higher for TR than for ME ( Fig. 6A , Table   222 1). To address the possibility that the MEgO-specific antibodies were simply less efficient at 223 capturing MEgO from ME extracts, similar experiments were performed with the TR-ME 224 heterologous gO recombinants ( Fig 6B, Table 2 ). Again, gH and gL were similar between 225 TR_MEgO and ME_TRgO, but gO levels were approximately 20-fold lower higher for the TR-226 based virus. To address the hypothesis that differences in gO expression between TR and ME 227 reflect differences in protein turnover, the [35]S-methionine/cysteine label was chased for up to 228 6 hours ( Fig 7) . The pattern of gH detection over the chase time was very similar in both TR 229 and ME samples. In both cases, labeled gH dropped to 60% after 3 hours and to 30-40% after 230 6 hours. The pattern of gO detection for both TR and ME was comparable to that of gH.
231
Together, these results confirmed that ME-infected cells express less gO than TR-infected cells, 232 and suggested differences in early steps of expression such as mRNA transcription, translation 233 or rapid ER-associated degradation, which can degrade proteins in the timescale of minutes 234 (34). 235
Overexpression of gO during ME replication increased gH/gL/gO assembly and 236 virus infectivity. To directly test the hypothesis that the low abundance of gH/gL/gO in ME 237 virions was due not simply to competition from the UL128-131 proteins, but also from low gO 238 expression, Ad vectors were used to increase gO levels during ME replication. Ad vectors 239 expressing GFP were used to control for potential effects of the Ad vectors themselves.
240
Consistent with the above analyses, gO levels were below the limits of immunoblot detection in 241 ME-infected nHDF or HFFF-tet cells, but gO was readily detected in cells superinfected with 242 AdMEgO (Fig 8A) . The overall expression of gL in ME infected cells was reduced by the 243 presence of either Ad vector ( Fig 8A) . In the case of the control AdGFP, the lower intracellular 244 gL correlated with reduced gH/gL/gO complexes in virions from HFFFtet cells (ME-T) ( Fig 8B) , 245 and this in turn correlated with reduced infectivity (i.e., increased particle PFU ratio) ( Fig 9) . The masked by the overall higher amounts of gH/gL and much lower infectivity of these virions ( Fig   248   8B , and Fig. 9 ). Controlling for the "Ad effect", AdMEgO expression in HFFFtet increased the 249 amounts of gH/gL/gO in ME-T virions compared to the AdGFP, and this resulted in a 6-fold 250 enhancement of infectivity, beyond the 40-fold enhanced infectivity resulting from repression of 251 UL128-131 alone ( Fig 8B, and Fig. 9 ). By contrast, AdMEgO expression had little effect on the 252 virions from HFF cells.
253
DISCUSSION
254
Recent population genetic studies have demonstrated a greater degree of genetic 255 diversity of HCMV in clinical specimens than had been previously appreciated (35, 36) (37). 256
The cell type and propagation methods likely narrow the resultant genotypes by purifying 257 selection (38, 39) . During propagation in cultured fibroblasts, inactivating mutations in the 258 UL128-131 ORFs are rapidly selected in a BAC clone of ME, and this selective pressure can be 259 relieved by transcriptional repression of the UL131 promoter, which reduces expression of the 260 pentameric gH/gL/UL128-131 (33) In contrast, the UL128-131 ORFs are more stable in 261 BAC clones of strain TR, and TB (39, 40). The UL128-131 ORF of TB contains a single 262 nucleotide polymorphism relative to ME that reduces splicing of the mRNA encoding the UL128 263 protein, which may help stabilize the UL128-131 ORFs through reduced expression of 264 gH/gL/UL128-131 (40). However, TR is identical to ME at this nucleotide position, and a 265 recombinant ME in which the UL128-131 locus was replaced with the UL128-131 sequences 266 from TR was as sensitive to selective inactivation of the locus as was wild type ME (40). 267
Together, these observations suggest that factors beyond expression level of the UL128-131 268 proteins can influence the selective pressures on the UL128-131 ORFs.
269
The results reported here demonstrated that TR and ME differ in stoichiometry of 270 expression of gO and UL128-131, and this seems to be a major factor determining the free virion. Fibroblasts infected with TR or ME were found to be comparable in the steady state 273 levels of gH/gL, but ME-infected cells contained more UL128-131 than TR infected cells. In ME-274 infected cells, most of the gH/gL was an ER-associated form, whereas TR-infected cells 275 contained a large amount of Golgi-associated gH/gL. This correlated well with the previous 276 observations that TR contained more total gH/gL than ME virions (25, 30) . The amount of 277
Golgi-associated gH/gL in ME-infected cells was reduced when expression of the UL128-131 278 proteins was repressed, consistent with the observation that most of the gH/gL in ME virions 279 was in the form of gH/gL/UL128-131 (25, 30) . Comparison of gO expression between strains 280 was complicated because the amino acid sequence differences between genotypes affected 281 antibody recognition (30). To circumvent this caveat, recombinant HCMV were engineered in 282 which the UL74(gO) ORF of TR were replaced with the homologous sequences of ME, and vice 283 versa. This approach allowed the analysis of expression of both gO isoforms in both genetic 284 backgrounds eliminating the possibility that the results were due to differences in antibody-285 antigen affinities. Immunoblot and radiolabeling experiments clearly demonstrated that ME-286 infected cells contained less gO than TR-infected cells. Overexpression of gO during ME 287 replication had no effect on levels of gH/gL/gO, or infectivity of the virions unless UL128-131 288 proteins were also transcriptionally repressed, and even then gH/gL/gO levels and infectivity 289 were only modestly enhanced. Together these results underscore the competition between gO 290 and UL128-131 for binding to gH/gL, and suggest other factors may influence the efficiency of 291 gH/gL/gO assembly.
292
The molecular mechanisms underpinning the discrepancy between TR and ME in 293 expression UL128-131, and gO remain unclear. As mentioned above, Murrell 2013 described a 294 SNP in the TB UL128-131 locus that affected mRNA splicing, in part explaining the lower 295 expression of these proteins in TB (40). However, this splicing effect does not explain the 296 difference in UL128-131 expression between TR and ME since these strains are conserved at this nucleotide position. For gO, the radiolabeling analyses reported in Figures 6 and 7 , 298 suggest the differences are due to early events in UL74(gO) expression such as transcription, 299 mRNA processing/stability, translation, or rapid ER-associated degradation occurring in the 300 timescale of minutes (34). Attempts to analyze UL74(gO) mRNA levels between TR and ME by 301 quantitative RT-PCR were complicated by the fact that HCMV genomes contain many 302 overlapping RNAPII transcription units that vary between strains (41, 42). It is interesting that 303 ME-infected cells contained less UL148 than TR-infected cells. UL148 was first described as an 304 ER-resident chaperone protein that promotes the assembly of gH/gL/gO (32). The mechanism 305 may well involve interactions between UL148 and the cellular ER-associated degradation 
308
The TR-ME heterologous gO recombinant viruses also allowed analysis of the effects of 309 gO amino acid sequence differences on assembly of gH/gL complexes and the function of gO in 310 entry. No differences between TR and TRMEgO or between ME and METRgO were 311 observed in either the amounts of gH/gL complexes in virions, or cell free infectivity. These 312 results argue against the notion that the amino acid sequence differences between gO 313 genotypes affect interactions with gH/gL or the binding of the fibroblast entry receptor,
314
PDGFR. Interestingly Kalser 2017 showed that replacing the endogenous gO of TB with the 315 gO from Towne did not alter replication in cultured fibroblasts, but did enhance replication in 316 epithelial cell cultures. (43). Thus, it may be that gO sequence variation affects interactions 317 with receptors other than PDGFR that mediated infection of epithelial cells.
318
Laib-Sampaio 2016 reported that mutational disruption of UL74(gO) expression in ME 319 had little effect on replication unless the UL128-131 locus was also disrupted (24). These 320 authors suggested that spread of ME was mediated principally by gH/gL/UL128-131 in a cell-manner mediated by gH/gL/gO. This is in stark contrast to the dramatic phenotype reported for 323 a gO null TR mutant (22). Our finding that expression of gO by ME is low compared to TR may 324 provide a partial explanation of these different gO null phenotypes.
325
It remains unclear whether the described difference in gO expression between TR and 326 ME represents a bona fide variation that naturally exists between HCMV genotypes in vivo, or 327 reflects differential selection on de novo mutations that occurred during the independent 328 isolation of these strains from clinical specimens. It seems clear that serial propagation of ME in 329 cultured fibroblasts selects for de novo mutations that reduce or abolish the robust expression of 330 the UL128-131 proteins (33, 39) . The selective pressure that fixes these mutations in the 331 culture population may be explained by the specific infectivity analyses reported here (Figs. 3 332 and 9) and in Zhou 2015 (25). In both analyses the specific infectivity of TR was measured at 333 approximately 100-200 particles/PFU, whereas ME was more 30-50-fold less infectious.
334
Repression of the UL128-131 proteins enhanced the infectivity of ME ("ME-T") to levels 335 comparable to TR (approximately 100 particles/PFU). While the infectivity of ME-T and TR 336 virions was comparable, ME-T virions still contained far less gH/gL/gO than TR (Fig 4, and   337 ( (25)). Ad vector overexpression of gO enhanced infectivity of ME only 6-fold beyond the 338 enhancement due to UL128-131 repression alone ( Fig. 8 and 9 ). Together, these observations 339 would seem to suggest that in vitro selective pressures for reduced UL128-131 expression are 340 much more pronounced than any for enhanced gO expression. Thus, it is possible that the 341 difference in gO expression between HCMV TR and ME derives not from selection on de novo 342 mutations occurring during propagation in culture, but from nonselective, random sampling of 343 the multitude of different genotypes that likely preexist in clinical specimens (35, 36) (37). 344
Distinguishing these possibilities will require clear identification of the genomic sequences that still visually intact), culture supernatants were harvested, and cellular contaminants were 363 removed by centrifugation at 1,000 X g for 10min, and again at 6,000 X g for 10min. Stocks 364 were judged cell-free by the lack of calnexin, and actin in western blot analyses, and then stored 365 at -80°C. Freeze/thaw cycles were avoided. Plaque-forming-units were determined by plating a 366 series of 10-fold dilutions of each stock on replicate cultures of HFF for 2h at 37° C, and 367 replacing the inoculum with a DMEM supplemented with 5% FBS, and 0.6% SeaPlaque 368 agarose (to limit cell free spread). Plaques were counted by light microscopy 3 weeks after 369 infection.
370
Heterologous UL74(gO) recombinant HCMV. A two step BAC recombineering from start codon to stop codon of both TR and ME was replaced by a selectable marker.
373
Briefly, overnight cultures of SW102 E. coli containing either the BAC clone of TR or ME were 374 grown at 32° C until OD600=0.55. Recombination genes were induced by incubating at 42° C 
388
In the second step, the selectable marker cassette in the TR and ME first-step 389 intermediate BACs was replaced with the UL74(gO) sequence from the heterologous strain.
390
Briefly, E. coli were prepared for recombination as described for step one above, and 391 electroporated with purified PCR products containing the UL74 ORF from TR or ME strain 
409
Antibodies. Rabbit polyclonal anti-peptide antibodies specific for TBgO and MEgO were 410 described previously (30). Rabbit polyclonal antibodies specific for UL148 were described 411 (32). Rabbit polyclonal, anti-peptide antibodies against gH, gL, UL130 and UL131 were 412 
510
[35]-S cysteine/methionine for 15 minutes and then label was chased for 0, 10, 60, 180, or 360 DTT, heated to 75° C for 10 min, cooled to room temperature and then diluted 35-fold.
513
Immunoprecipitation was performed with anti-gH, gO (TR or ME specific) antibodies and At 5 dpi, infected cells were metabolically labeled with [35]-S cysteine/methionine for 15 min and membrane proteins were extracted in 1% Triton X-100. All samples were adjusted to 2%SDS/30mM DTT, heated to 75° C for 10 min, cooled to room temperature and then diluted 35-fold. Parallel immunoprecipitations were performed in which equal amounts of anti-gH, gL, or gO (TR or ME specific) antibodies were reacted with 3-fold increasing amounts of protein extract as input, and precipitated proteins were analyzed by reducing SDS-PAGE. 9251.8 420.5 478.9 20.0 21.1 27.2 (+/-9.4) a. 7uL of rabbit anti-peptide serum per immunoprecipitation reaction b. Preparation of radiolabeled cell extracts described in legend to Figure 6 , and in materials and methods. c. Densities of bands shown in Figure 6A as determined using Image J v. 1.48 d. Band density not detected. e. Density divided by the predicted number of methionine and cysteine residues: TRgH(30), MEgH(31), TRgL(13), MEgL(13), TRgO (22), MEgO(24) f. Adjusted density TR divided by adjusted density ME. g. Average fold difference between TR and ME +/-standard deviation. 460.1 20.9 20.9 19.7 (+/-1.7) a. 7uL of rabbit anti-peptide serum per immunoprecipitation reaction b. Preparation of radiolabeled cell extracts described in legend to Figure 6 , and in materials and methods. c. Densities of bands shown in Figure 6B as determined using Image J v. 1.48 d. Band density not detected. e. Density divided by the predicted number of methionine and cysteine residues: TRgH(30), MEgH(31), TRgL(13), MEgL(13), TRgO (22), MEgO(24) f. Adjusted density TR_MEgO divided by adjusted density ME_TRgO. g. Average fold difference between TR_MEgO and ME_TRgO +/-standard deviation.
